Breaking News Instant updates and real-time market news.

DMTX

Acquired by RARE

, RGNX

Regenxbio

$21.70

0.65 (3.09%)

08:41
08/25/17
08/25
08:41
08/25/17
08:41

Regenxbio holds a conference call

Conference call to discuss the acquisition of Dimension Therapeutics is being held on August 25 at 8:30 am. Webcast Link

DMTX

Acquired by RARE

RGNX

Regenxbio

$21.70

0.65 (3.09%)

  • 11

    Sep

DMTX Acquired by RARE

05/12/17
SBSH
05/12/17
DOWNGRADE
Target $1.5
SBSH
Neutral
Dimension Therapeutics downgraded to Neutral from Buy at Citi
Citi analyst Joel Beatty downgraded Dimension Therapeutics to Neutral after the company announced the discontinuation of its hemophilia B gene therapy program. The analyst says he's more cautious on the shares since a safety update on hemophilia B hasn't been disclosed since the program was discontinued. He cut his price target for the shares to $1.50 from $4.
01/31/17
CANT
01/31/17
DOWNGRADE
Target $3
CANT
Neutral
Dimension Therapeutics downgraded to Neutral from Overweight at Cantor
Cantor Fitzgerald analyst Elemer Piros downgraded Dimension Therapeutics to Neutral and cut his price target for the shares to $3 from $32 saying the Phase 1/2 study in Hemophilia B highlighted that DTX101 will require additional optimization to be competitive with currently ongoing Hemophilia B gene therapy programs. The stock is down 50% to $2.12 in midday trading.
RGNX Regenxbio
$21.70

0.65 (3.09%)

08/16/17
EVER
08/16/17
INITIATION
Target $25
EVER
Outperform
Regenxbio initiated with an Outperform at Evercore ISI
Evercore ISI analyst Josh Schimmer initiated Regenxbio with an Outperform and a $25 price target.
04/11/17
CHDN
04/11/17
NO CHANGE
Target $50
CHDN
Buy
REGENXBIO price target raised to $50 from $35 at Chardan
Chardan analyst Gbola Amusa raised his price target on REGENXBIO (RGNX) to $50 from $35, calling the company's appointment of Olivier Danos from Biogen (BIIB) as Chief Scientific Officer a "watershed moment" that increases his conviction in the company's long-term prospects. Amusa keeps a Buy rating on REGENXBIO shares.
03/21/17
03/21/17
NO CHANGE

REGENXBIO files to sell $75M in common stock
Morgan Stanley, BofA Merrill Lynch and Piper Jaffray & Co. are acting as joint book-running managers. Chardan Capital Markets, LLC is acting as co-manager of the offering.

TODAY'S FREE FLY STORIES

C

Citi

$77.13

0.67 (0.88%)

10:20
02/21/18
02/21
10:20
02/21/18
10:20
Options
Sizable option prints in Citi as shares rally Wednesday »

Sizable option prints in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 06

    Mar

  • 07

    Mar

  • 30

    May

DLR

Digital Realty

$97.72

-1.865 (-1.87%)

10:20
02/21/18
02/21
10:20
02/21/18
10:20
Periodicals
Supreme Court throws out lawsuit against Digital Realty Trust »

Company whistleblowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 05

    Mar

  • 27

    Mar

  • 03

    Apr

WD

Walker & Dunlop

$50.29

0.13 (0.26%)

10:20
02/21/18
02/21
10:20
02/21/18
10:20
Conference/Events
Walker & Dunlop management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

10:20
02/21/18
02/21
10:20
02/21/18
10:20
General news
Fed's Kashkari said "Wall Street reacts to everything," »

Fed's Kashkari said…

$NSD

NASDAQ Market Internals

10:17
02/21/18
02/21
10:17
02/21/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

10:16
02/21/18
02/21
10:16
02/21/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMER

Omeros

$11.37

0.36 (3.27%)

10:14
02/21/18
02/21
10:14
02/21/18
10:14
Periodicals
Symphony data show Omidria sales fell 87% in January, Four World says »

Short seller Four World…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COLL

Collegium Pharmaceutical

$25.70

-0.2 (-0.77%)

10:12
02/21/18
02/21
10:12
02/21/18
10:12
Hot Stocks
FDA says Collegium made false or misleading claims about Xtampza »

The FDA posted a letter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 01

    Mar

VECO

Veeco

$18.35

-0.55 (-2.91%)

10:11
02/21/18
02/21
10:11
02/21/18
10:11
Conference/Events
Veeco management to meet with KeyBanc »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

CLF

Cleveland-Cliffs

$7.62

-0.12 (-1.55%)

10:10
02/21/18
02/21
10:10
02/21/18
10:10
Options
Bearish option flow in Cleveland Cliffs »

Bearish option flow in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:10
02/21/18
02/21
10:10
02/21/18
10:10
General news
U.S. existing home sales preview: »

U.S. existing home sales…

MTCH

Match Group

$42.10

0.54 (1.30%)

, IAC

IAC

$149.83

0.74 (0.50%)

10:09
02/21/18
02/21
10:09
02/21/18
10:09
Hot Stocks
Match Group slips after analyst cuts rating on Tinder slowdown »

Shares of Match Group…

MTCH

Match Group

$42.10

0.54 (1.30%)

IAC

IAC

$149.83

0.74 (0.50%)

ANGI

Angi Homeservices

$14.60

0.58 (4.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

MOS

Mosaic

$27.78

1.0176 (3.80%)

10:05
02/21/18
02/21
10:05
02/21/18
10:05
Options
Mosaic call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 28

    Feb

10:05
02/21/18
02/21
10:05
02/21/18
10:05
General news
More from Harker: a trade war would not be good »

More from Harker: a trade…

ABBV

AbbVie

$120.00

2.02 (1.71%)

10:05
02/21/18
02/21
10:05
02/21/18
10:05
Recommendations
AbbVie analyst commentary  »

Piper says 'hard to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

10:04
02/21/18
02/21
10:04
02/21/18
10:04
General news
Existing Home Sales data reported »

January Existing Home…

RDWR

Radware

$21.09

-0.25 (-1.17%)

10:04
02/21/18
02/21
10:04
02/21/18
10:04
Conference/Events
Radware management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 29

    Mar

RDWR

Radware

$21.09

-0.25 (-1.17%)

10:01
02/21/18
02/21
10:01
02/21/18
10:01
Conference/Events
Radware management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 29

    Mar

QTWO

Q2 Holdings

$42.85

-1.8 (-4.03%)

10:00
02/21/18
02/21
10:00
02/21/18
10:00
Conference/Events
Q2 Holdings management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 15

    Mar

10:00
02/21/18
02/21
10:00
02/21/18
10:00
General news
U.S. Markit manufacturing PMI rose 0.4 points to 55.9 in the flash February »

U.S. Markit manufacturing…

LFUS

Littelfuse

$208.66

0.61 (0.29%)

09:59
02/21/18
02/21
09:59
02/21/18
09:59
Conference/Events
Littelfuse management to meet with Oppenheimer »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

NJDCY

Nidec

$37.80

-0.12 (-0.32%)

09:57
02/21/18
02/21
09:57
02/21/18
09:57
Conference/Events
Nidec management to meet with Oppenheimer »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

HDP

Hortonworks

$18.22

0.03 (0.16%)

09:55
02/21/18
02/21
09:55
02/21/18
09:55
Conference/Events
Hortonworks management to meet with Northland »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

  • 26

    Feb

  • 11

    Mar

  • 13

    Mar

  • 14

    Mar

  • 11

    Apr

  • 30

    May

PVG

Pretium Resources

$6.56

-0.05 (-0.76%)

09:55
02/21/18
02/21
09:55
02/21/18
09:55
Options
Pretium Resources put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Mar

  • 11

    Mar

AAP

Advance Auto Parts

$115.88

10.53 (10.00%)

, EXR

Extra Space Storage

$84.86

4.105 (5.08%)

09:55
02/21/18
02/21
09:55
02/21/18
09:55
Options
Early notable gainers among liquid option names on February 21st »

Notable gainers among…

AAP

Advance Auto Parts

$115.88

10.53 (10.00%)

EXR

Extra Space Storage

$84.86

4.105 (5.08%)

MOS

Mosaic

$27.48

0.72 (2.69%)

CF

CF Industries

$42.80

0.975 (2.33%)

VRSK

Verisk Analytics

$97.04

-1.75 (-1.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 25

    Feb

  • 25

    Feb

  • 28

    Feb

  • 30

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.